The GuardianThe Guardian

Covid vaccine designed to target two variants approved for use in UK

By Nicola Davis

15 Aug 2022 · 2 min read

Editor's Note

You should read this story to know about a new vaccine by Moderna that not only targets the original strain of Sars-Cov2 but also the Omicron BA.1 sub-variant.

A vaccine designed to target two different forms of Covid has been approved by the UK regulator for use as booster jabs in people over the age of 18.

Manufactured by the US firm Moderna, the vaccine targets not only the original coronavirus – as is the case for vaccines currently in use – but is designed specifically to target the Omicron variant BA.1, which fuelled a wave of Covid in the UK last winter.

Sign in to informed

  • Curated articles from premium publishers, ad-free
  • Concise Daily Briefs with quick-read summaries
  • Read, listen, save for later, or enjoy offline
  • Enjoy personalized content